Skip to content

CARDIFF ONCOLOGY, INC.: 10-K filed 2013-04-01

What CARDIFF ONCOLOGY, INC. reported in its annual report filed 2013-04-01 (fiscal FY 2012): 28 published measures, 92 facts as tagged in accession 0001104659-13-026211.

This filing

Form
10-K (annual report)
Filed
2013-04-01
Fiscal period
fiscal FY 2012
Accession
0001104659-13-026211 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CARDIFF ONCOLOGY, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-3111,665,026USD
At 2011-12-311,039,257USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-319,495,998USD
At 2011-12-315,270,525USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-312,169,028USD
At 2011-12-31-4,231,268USD
At 2010-12-31-4,995,365USD
At 2009-12-31-3,786,709USD
At 2008-12-31-4,047,807USD
At 2007-12-31-1,645,793USD
At 2007-01-311,129,659USD
At 2006-01-313,480,710USD
At 2005-01-313,190,935USD
At 2004-01-31-1,578,125USD
At 2003-01-31-1,195,104USD
At 2002-01-31-719,395USD
At 2001-01-31-240,359USD
At 2000-01-3127,240USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-3110,819,781USD
At 2011-12-31700,374USD
At 2010-12-3158,703USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-11,565,961USD366
1999-08-04 to 2012-12-31-53,608,133USD4899
2012-04-01 to 2012-06-30-3,426,410USD91
2011-01-01 to 2011-12-31-2,239,212USD365
2011-04-01 to 2011-06-30-449,159USD91
2011-01-01 to 2011-06-30-1,001,144USD181
2010-01-01 to 2010-12-31-5,449,138USD365
2009-01-01 to 2009-12-31-2,483,807USD365
2008-01-01 to 2008-12-31-5,166,240USD366
2007-02-01 to 2007-12-31-4,683,141USD334
2006-02-01 to 2007-01-31-7,134,067USD365
2005-02-01 to 2006-01-31-7,844,326USD365
2004-02-01 to 2005-01-31-5,371,027USD366
2003-02-01 to 2004-01-31-383,021USD365
2002-02-01 to 2003-01-31-481,609USD365
2001-02-01 to 2002-01-31-524,224USD365
2000-02-01 to 2001-01-31-267,599USD366
1999-08-04 to 2000-01-31-14,760USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-31270,080USD366
1999-08-04 to 2012-12-31514,383USD4899
2011-01-01 to 2011-12-311,528USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-55,202,632USD
At 2011-12-31-43,598,431USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-31254,742USD
At 2011-12-3122,504USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-31532,140USD366
1999-08-04 to 2012-12-3112,012,465USD4899
2011-01-01 to 2011-12-31250,978USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-4,849,156USD366
1999-08-04 to 2012-12-31-43,577,787USD4899
2011-01-01 to 2011-12-31-2,976,803USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-3111,048,203USD
At 2011-12-31842,172USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
1999-08-04 to 2012-12-311,325,372USD4899
2011-01-01 to 2011-12-3156,636USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-31730,370USD
At 2011-12-311,429,881USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-31175,679USD
At 2011-12-31928,364USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-12-31168,381USD
At 2011-12-3199,140USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
1999-08-04 to 2012-12-31500,000USD4899

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3115,478,177shares
At 2011-12-3110,737,026shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-3157,370,017USD
At 2011-12-3139,365,994USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-31514,383USD
At 2011-12-31244,303USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-31259,641USD
At 2011-12-31221,799USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-31362,081USD
At 2011-12-31174,581USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-12-31554,691USD
At 2011-12-31501,517USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-12-3160,041USD
At 2011-12-3142,658USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-11,604,201USD366
1999-08-04 to 2012-12-31-55,202,632USD4899
2011-01-01 to 2011-12-31-2,277,452USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,379,262USD366
1999-08-04 to 2012-12-3125,920,116USD4899
2011-01-01 to 2011-12-312,323,814USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-12-3137,842USD366
1999-08-04 to 2012-12-31259,641USD4899
2011-01-01 to 2011-12-3110,285USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-12-3115,323,548USD366
1999-08-04 to 2012-12-3132,755,551USD4899
2011-01-01 to 2011-12-312,573,500USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-3169,241USD366
1999-08-04 to 2012-12-31168,382USD4899
2011-01-01 to 2011-12-3124,140USD365

Inspect the source

Entity
CARDIFF ONCOLOGY, INC. / CIK 0001213037
Captured
2026-09-20T07:45:48.177Z
SEC response SHA-256
5fefa7380123168da913afadb8db67f9296559e6467fa58ab3879c6c623fb326

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001213037.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))